Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Junichi Ohshiro"'
Autor:
Fukunori Kinjo, Akira Hokama, M. Maehara, Izuru Gakiya, Hayashi Shokita, Saito A, Hiroyuki Uechi, Uehara T, Junichi Ohshiro
Publikováno v:
Nippon Daicho Komonbyo Gakkai Zasshi. 49:355-362
クローン病患者18例に対し超音波検査を行い, 13例 (72%) で腸管壁の肥厚が認められた.小腸病変, 大腸病変で検出率に差はなかった.壁肥厚として認められたのは29病変であり, 壁厚の平均は4
Autor:
Fukunori Kinjo, Atsushi Saito, Shikiya K, Junichi Ohshiro, Niimura S, Osamu Zaha, Ryuji Asato, Uehara T
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 68:13-20
We treated 125 patients with strongyloidiasis (78 males and 47 females) by 2 oral doses of ivermectin (6 mg) at 2-week interval, and obtained the following results: 1. Eradication rate after treatment was 86.4% (108 of 125 patients), responsively. Ou
Autor:
Atsushi Saito, Ryuji Asato, Hiroshi Sakugawa, Junichi Ohshiro, Shikiya K, Hiroyuki Uechi, Uehara T, Tominori Oyakawa, Tamiki Arakaki, Fukunori Kinjo
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 65:1085-1090
We previously reported the efficacy of ivermectin (IVM) for the treatment of 23 strongyloidiasis patients. We now reported the efficacy and safety of IVM therapy on 54 patients. Fifty-four patients, 28 males and 26 females, received a single oral dos
Autor:
Osamu ZAHA, Seisho NIIMURA, Nagisa KINJO, Minoru IKEMA, Hiroshi NAKAMURA, Takeshi UEHARA, Hiroyuki UECHI, Junichi OHSHIRO, Koushin SHIKIYA, Fukunori KINJO, Atsushi SAITO
Publikováno v:
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases. 66(10)
We treated strongyloidiasis patients and obtained the following results: Of the 299 patients (184 males and 115 females), 81 patients (27.1%) had no complaints before treatment, 218 patients complaints of some symptoms, including arthralgia and/or lu
Autor:
Seisyo NIIMURA, Tetsuo HIRATA, Osamu ZAHA, Hiroshi NAKAMURA, Akihiko KOUCHI, Takeshi UEHARA, Hiroyuki UECHI, Junichi OHSHIRO, Koushin SHIKIYA, Fukunori KINJO, Atsushi SAITO
Publikováno v:
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases. 66(9)
We reported the efficacy of albendazole (ABZ) for the treatment of 27 patients with strongyloidiasis. Twenty-seven patients, 23 males and 4 females, received 200 mg of ABZ one hour before breakfast and supper for 3 days and this treatment was repeate
Autor:
Koushin SHIKIYA, Osamu ZAHA, Seisho NIIMURA, Hiroshi NAKAMURA, Tomokuni NAKAYOSHI, Akihiko KOCHI, Takeshi UEHARA, Hiroyuki UECHI, Junichi OHSHIRO, Fukunori KINJO, Atsushi SAITO
Publikováno v:
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases. 66(7)
We treated 70 patients with strongyloidiasis (41 males and 29 females) with ivermectin (IVM), and obtained the following results: 1. The eradication rates at 1-2 months, 3-4 months and 5-6 months after treatment were 90.7% (49 of 54 patients), 100.0%
Autor:
Shikiya K, Nagisa Kinjo, Uehara T, Hiroyuki Uechi, Atsushi Saito, Kazumine Kobari, Tamiki Arakaki, Fukunori Kinjo, Junichi Ohshiro, Mamoru Iju
Publikováno v:
Internal medicine (Tokyo, Japan). 31(3)
Okinawa Prefecture is an endemic area of Strongyloides stercoralis infection. Since treatment of this infection remains unsatisfactory, we evaluated the efficacy of ivermectin. Twenty-three patients were treated with a single oral dose of ivermectin